Contemporary Management of Metastatic Renal Cell Carcinoma

EP. 1: Pembrolizumab Plus Axitinib for Advanced RCC

July 29th 2019

EP. 2: Additive and Overlapping Adverse Effects of RCC Therapy

July 29th 2019

EP. 3: CheckMate 214 Trial for Newly Diagnosed Metastatic RCC

July 29th 2019

EP. 4: Cytoreductive Nephrectomy in Metastatic RCC

July 29th 2019

EP. 5: NCCN Guideline Changes for First- & Beyond-First-Line RCC Therapy

July 29th 2019

EP. 6: Role of Risk Stratification in Treatment Planning for mRCC

July 29th 2019

EP. 7: Patient-Reported Outcomes for RCC Treatment Therapies

July 29th 2019

EP. 8: Factors Influencing Choice of Sequential Therapy in RCC

July 29th 2019

EP. 9: Tyrosine Kinase Inhibitors Used Alone or in Combination to Treat RCC

July 29th 2019

EP. 10: Safety and Tolerability Influence the Use of TKIs in RCC

July 29th 2019

EP. 11: Third-Line Therapy and Beyond in Treating Metastatic RCC

July 29th 2019

EP. 12: Ongoing Clinical Trials for Metastatic RCC

July 29th 2019

EP. 13: NKTR-214 and COSMIC-313 for Previously Untreated RCC

July 29th 2019

EP. 14: Biomarkers: Guide to Clinical Decision Making to Treat mRCC

July 29th 2019

EP. 15: Advances and Challenges Faced in the Treatment of mRCC

July 29th 2019